Zahangir Hosain
Zahangir Hosain has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Mostofa Kamal
Bangladesh Livestock Research Institute
3 shared publications - Yoshiki Katayama
Graduate School of Systems Life Sciences, Kyushu University, Fukuoka 819-0395, Japan
3 shared publications Akihiro Kishimura
A Graduate School of Systems Life Sciences , Kyushu University , Nishi-ku , Japan
2 shared publications- Akihiro Kishimura
Department of Applied Chemistry, Faculty of Engineering, Kyushu University, Fukuoka, Japan
2 shared publications Masafumi Takeo
Graduate School of Systems Life Sciences , Kyushu University , 744 Motooka, Nishi-ku , Fukuoka 819-0395 , Japan .;; ; Tel: +81 92 802 2851
2 shared publications- S. M. Lutful Kabir
Bangladesh Agricultural University
2 shared publications
Latest Publications
- Open Access
- 23 March 2026
- Published by Veterinary World in Veterinary World
- Vol. 19 (3) , 1300-1321
Status, challenges, and future prospects of veterinary vaccines for sustainable livestock production in Bangladesh
Background and Aim: Veterinary vaccines are crucial tools for preventing infectious diseases, boosting animal productivity, and supporting sustainable livestock farming. This review examines the current status, challenges, and future outlook of veterinary vaccine development, production, and use in Bangladesh. The livestock sector in Bangladesh is vital for food security, rural livelihoods, and the national economy, contributing about 1.8% to the gross domestic product and supporting millions of farmers. Yet, the sector continues to suffer significant losses from infectious diseases such as foot-and-Mouth Disease, Peste des Petits ruminants, anthrax, hemorrhagic septicemia, Newcastle disease, and avian influenza. Therefore, effective vaccination programs are essential for disease control and improving livestock productivity. Bangladesh has gradually increased its veterinary vaccine production capacity through institutions such as the Livestock Research Institute and the Bangladesh Livestock Research Institute, with growing participation from private pharmaceutical companies. Over the past decade, vaccine production has risen from approximately 236 million doses in 2015–2016 to about 327 million doses in 2024–2025. Despite this progress, domestic production still falls short of meeting national demand. Current estimates show that locally produced vaccines cover only about 23%–27% of the demand for ruminant vaccines and roughly 6%–13% for poultry vaccines, leading to a heavy dependence on imported vaccines. Major challenges facing the veterinary vaccine sector include limited production capacity, outdated manufacturing infrastructure, lack of advanced vaccine technologies, regulatory hurdles, weak cold-chain logistics, and insufficient investment in research and development. Nevertheless, Bangladesh has significant opportunities to strengthen its veterinary vaccine ecosystem. Advances in molecular biology, recombinant vaccine technologies, genomic surveillance, and thermostable vaccine development offer promising pathways to improve vaccine efficacy and accessibility. Additionally, better collaboration between public institutions, academia, and private industry, along with supportive government policies and stronger regulatory frameworks, could greatly expand local vaccine production and lessen reliance on imports. Overall, strengthening veterinary vaccine research, manufacturing capacity, quality assurance systems, and distribution infrastructure is crucial for achieving sustainable livestock production in Bangladesh. Improved vaccine access and coverage will not only boost livestock productivity but also support food security, reduce economic losses, and contribute to national and global One Health goals. Keywords: Bangladesh, disease control, import dependency, livestock production, One Health, vaccine production, veterinary vaccines, zoonotic diseases.
- 23 March 2026
- Published by Veterinary World in Veterinary World
- Vol. 19 (3) , 1300-1321
Open AccessStatus, challenges, and future prospects of veterinary vaccines for sustainable livestock production in Bangladesh
Background and Aim: Veterinary vaccines are crucial tools for preventing infectious diseases, boosting animal productivity, and supporting sustainable livestock farming. This review examines the current status, challenges, and future outlook of veterinary vaccine development, production, and use in Bangladesh. The livestock sector in Bangladesh is vital for food security, rural livelihoods, and the national economy, contributing about 1.8% to the gross domestic product and supporting millions of farmers. Yet, the sector continues to suffer significant losses from infectious diseases such as foot-and-Mouth Disease, Peste des Petits ruminants, anthrax, hemorrhagic septicemia, Newcastle disease, and avian influenza. Therefore, effective vaccination programs are essential for disease control and improving livestock productivity. Bangladesh has gradually increased its veterinary vaccine production capacity through institutions such as the Livestock Research Institute and the Bangladesh Livestock Research Institute, with growing participation from private pharmaceutical companies. Over the past decade, vaccine production has risen from approximately 236 million doses in 2015–2016 to about 327 million doses in 2024–2025. Despite this progress, domestic production still falls short of meeting national demand. Current estimates show that locally produced vaccines cover only about 23%–27% of the demand for ruminant vaccines and roughly 6%–13% for poultry vaccines, leading to a heavy dependence on imported vaccines. Major challenges facing the veterinary vaccine sector include limited production capacity, outdated manufacturing infrastructure, lack of advanced vaccine technologies, regulatory hurdles, weak cold-chain logistics, and insufficient investment in research and development. Nevertheless, Bangladesh has significant opportunities to strengthen its veterinary vaccine ecosystem. Advances in molecular biology, recombinant vaccine technologies, genomic surveillance, and thermostable vaccine development offer promising pathways to improve vaccine efficacy and accessibility. Additionally, better collaboration between public institutions, academia, and private industry, along with supportive government policies and stronger regulatory frameworks, could greatly expand local vaccine production and lessen reliance on imports. Overall, strengthening veterinary vaccine research, manufacturing capacity, quality assurance systems, and distribution infrastructure is crucial for achieving sustainable livestock production in Bangladesh. Improved vaccine access and coverage will not only boost livestock productivity but also support food security, reduce economic losses, and contribute to national and global One Health goals. Keywords: Bangladesh, disease control, import dependency, livestock production, One Health, vaccine production, veterinary vaccines, zoonotic diseases.
- Open Access
- 2 September 2025
- Published by Bangladesh Academy of Sciences in Asian-Australasian Journal of Bioscience and Biotechnology
- Vol. 10 (3) , 64-76
An overview of antimicrobial residues in animal-originated food products in developing countries
Antimicrobial residues in food products of animal origin represent a significant public health concern that requires careful consideration due to their harmful effects on consumer health. The presence of antibiotic residues in animal-derived food poses challenges for international trade involving animals and their products. Public health issues related to antibiotic residues in food include the emergence and spread of antimicrobial resistance (AMR), allergic reactions, cancer risks, genetic mutations, birth defects, bone marrow damage, and disruption of normal gut microbiota. The indiscriminate use of antibiotics in livestock can lead to residue levels that exceed permissible limits, resulting in adverse health effects for humans. Limiting antibiotic use is crucial for the safety of animal products. This review examines the administration of antibiotics to food animals, the presence of antibiotic residues in animal-origin foods, and the various factors that influence these residue levels in animal-derived food products in developing countries. It underscores the urgent need for improved regulatory control and surveillance of antibiotic use in food-producing animals to ensure public health safety. The findings highlight the importance of strengthening residue monitoring systems, enforcing withdrawal periods, and promoting responsible antibiotic stewardship to reduce contamination in animal-derived foods. Asian Australas. J. Biosci. Biotechnol. 2025, 10(3), 64-76
- 2 September 2025
- Published by Bangladesh Academy of Sciences in Asian-Australasian Journal of Bioscience and Biotechnology
- Vol. 10 (3) , 64-76
Open AccessAn overview of antimicrobial residues in animal-originated food products in developing countries
Antimicrobial residues in food products of animal origin represent a significant public health concern that requires careful consideration due to their harmful effects on consumer health. The presence of antibiotic residues in animal-derived food poses challenges for international trade involving animals and their products. Public health issues related to antibiotic residues in food include the emergence and spread of antimicrobial resistance (AMR), allergic reactions, cancer risks, genetic mutations, birth defects, bone marrow damage, and disruption of normal gut microbiota. The indiscriminate use of antibiotics in livestock can lead to residue levels that exceed permissible limits, resulting in adverse health effects for humans. Limiting antibiotic use is crucial for the safety of animal products. This review examines the administration of antibiotics to food animals, the presence of antibiotic residues in animal-origin foods, and the various factors that influence these residue levels in animal-derived food products in developing countries. It underscores the urgent need for improved regulatory control and surveillance of antibiotic use in food-producing animals to ensure public health safety. The findings highlight the importance of strengthening residue monitoring systems, enforcing withdrawal periods, and promoting responsible antibiotic stewardship to reduce contamination in animal-derived foods. Asian Australas. J. Biosci. Biotechnol. 2025, 10(3), 64-76
- Open Access
- 22 December 2022
- Published by Bangladesh Academy of Sciences in Asian-Australasian Journal of Bioscience and Biotechnology
- Vol. 7 (3) , 90-106
Recent trends and scenario of antibiotic use in veterinary practices for livestock production in Bangladesh: a review
Antibiotics are used for the treatment and control of diseases as well as a growth promoter in livestock production in Bangladesh. The frequent use of these antibiotics in veterinary practices may lead to residue and creates some potential problems not only in livestock but also in public health issues. The presence of residues of antibiotics in animal-derived foodstuffs may induce carcinogenic and mutagenic effects and leads to the condition of an allergic reaction, and the development of antibiotic resistance in human gut bacteria. Although misuse of antibiotics in human medicine is the principal cause of the problems, some antibiotic-resistant bacteria originating in animals may also be the contributory factors to the resistance. However, some of the antibiotic resistance problems can be attributed to the transfer of resistant bacteria from animals to humans and resistance genes from animal pathogens and commensal bacteria to human pathogens. Even though the antibiotics and their residues in feed and food products of animal origin cause serious public health problems but little is known by society due to the lack of proper information. So, this is important to review the uses of antibiotics in food animals and insight their public health significance in Bangladesh. However, the safety levels of animal feeds and food of animal origin must be strictly observed and the antibiotics should be used in accordance with the labeled directions public awareness should be developed about the indiscriminate use of antibiotics in animals and their hazardous residual impacts on the human body. Therefore, the present review focuses on the aspects of antibiotic use in the livestock production of Bangladesh. Asian Australas. J. Biosci. Biotechnol. 2022, 7 (3), 90-106
- 22 December 2022
- Published by Bangladesh Academy of Sciences in Asian-Australasian Journal of Bioscience and Biotechnology
- Vol. 7 (3) , 90-106
Open AccessRecent trends and scenario of antibiotic use in veterinary practices for livestock production in Bangladesh: a review
Antibiotics are used for the treatment and control of diseases as well as a growth promoter in livestock production in Bangladesh. The frequent use of these antibiotics in veterinary practices may lead to residue and creates some potential problems not only in livestock but also in public health issues. The presence of residues of antibiotics in animal-derived foodstuffs may induce carcinogenic and mutagenic effects and leads to the condition of an allergic reaction, and the development of antibiotic resistance in human gut bacteria. Although misuse of antibiotics in human medicine is the principal cause of the problems, some antibiotic-resistant bacteria originating in animals may also be the contributory factors to the resistance. However, some of the antibiotic resistance problems can be attributed to the transfer of resistant bacteria from animals to humans and resistance genes from animal pathogens and commensal bacteria to human pathogens. Even though the antibiotics and their residues in feed and food products of animal origin cause serious public health problems but little is known by society due to the lack of proper information. So, this is important to review the uses of antibiotics in food animals and insight their public health significance in Bangladesh. However, the safety levels of animal feeds and food of animal origin must be strictly observed and the antibiotics should be used in accordance with the labeled directions public awareness should be developed about the indiscriminate use of antibiotics in animals and their hazardous residual impacts on the human body. Therefore, the present review focuses on the aspects of antibiotic use in the livestock production of Bangladesh. Asian Australas. J. Biosci. Biotechnol. 2022, 7 (3), 90-106
- Open Access
- 8 December 2021
- Published by Veterinary World in Veterinary World
- Vol. 14 (12) , 3084-3090
Development of a rapid and reliable high-performance liquid chromatography method for determination of water-soluble vitamins in veterinary feed premix
Background and Aim: Determination of trace amounts of vitamins in multi-component feed premix is a troublesome analytical procedure. In this study, a simple and rapid high-performance liquid chromatography (HPLC) method was developed and validated for the concurrent detection and quantitation of four water-soluble vitamins such as thiamine, riboflavin, pyridoxine, and cyanocobalamin in veterinary feed premixes. Materials and Methods: The chromatographic separation of the vitamins was carried out at 35 degrees C temperature on a reversed-phase C18 column using a gradient pump mode. Mobile phase constituents were solvent (a): 25 mM Potassium dihydrogen phosphate and 5 mM sodium hexanesulfonate in deionized water having pH-4.0 and solvent and (b) 5 mM sodium hexanesulfonate in methanol. Detection was performed with HPLC ultraviolet/visible detection set at 278 and 361 tun wavelength in two different channels. The flow rate was 1.2 mL/min and the total run time was 25 min. Results: The method was validated according to the International Conference on Harmonization and Food and Drug Administration guidelines and acceptance criteria for system suitability, precision, linearity, and recovery center dot were met in all cases. The relative standard deviation for system suitability and precision was 0.999) at concentration of 5, 10, 15, 20, 25, and 30 mu g/mL for all vitamins. The limits of detection values were 0.0125, 0.0017, 0.0064, and 0.0065 mu g/mL for thiamine, riboflavin, pyridoxine, and cyanocobalamin, respectively, and the limits of quantification values were 0.0378, 0.0051, 0.0213, and 0.0198 mu g/mL for thiamine, riboflavin, pyridoxine, and cyanocobalamin, respectively. The recovery percentages ranged from 88% to 115%. Conclusion: The overall parameters of the proposed method met the validation criteria and this method could be a highly desirable technique for routine analysis of water-soluble vitamins in veterinary feed premix.
- 8 December 2021
- Published by Veterinary World in Veterinary World
- Vol. 14 (12) , 3084-3090
Open AccessDevelopment of a rapid and reliable high-performance liquid chromatography method for determination of water-soluble vitamins in veterinary feed premix
Background and Aim: Determination of trace amounts of vitamins in multi-component feed premix is a troublesome analytical procedure. In this study, a simple and rapid high-performance liquid chromatography (HPLC) method was developed and validated for the concurrent detection and quantitation of four water-soluble vitamins such as thiamine, riboflavin, pyridoxine, and cyanocobalamin in veterinary feed premixes. Materials and Methods: The chromatographic separation of the vitamins was carried out at 35 degrees C temperature on a reversed-phase C18 column using a gradient pump mode. Mobile phase constituents were solvent (a): 25 mM Potassium dihydrogen phosphate and 5 mM sodium hexanesulfonate in deionized water having pH-4.0 and solvent and (b) 5 mM sodium hexanesulfonate in methanol. Detection was performed with HPLC ultraviolet/visible detection set at 278 and 361 tun wavelength in two different channels. The flow rate was 1.2 mL/min and the total run time was 25 min. Results: The method was validated according to the International Conference on Harmonization and Food and Drug Administration guidelines and acceptance criteria for system suitability, precision, linearity, and recovery center dot were met in all cases. The relative standard deviation for system suitability and precision was 0.999) at concentration of 5, 10, 15, 20, 25, and 30 mu g/mL for all vitamins. The limits of detection values were 0.0125, 0.0017, 0.0064, and 0.0065 mu g/mL for thiamine, riboflavin, pyridoxine, and cyanocobalamin, respectively, and the limits of quantification values were 0.0378, 0.0051, 0.0213, and 0.0198 mu g/mL for thiamine, riboflavin, pyridoxine, and cyanocobalamin, respectively. The recovery percentages ranged from 88% to 115%. Conclusion: The overall parameters of the proposed method met the validation criteria and this method could be a highly desirable technique for routine analysis of water-soluble vitamins in veterinary feed premix.
- Top Cited PapersOpen Access
- 5 January 2021
- Published by Veterinary World in Veterinary World
- Vol. 14 (1) , 210-221
Antimicrobial uses for livestock production in developing countries
Antimicrobial is an indispensable part of veterinary medicine used for the treatment and control of diseases as well as a growth promoter in livestock production. Frequent use of antimicrobials in veterinary practices may lead to the residue in animal originated products and creates some potential problems for human health. The presence of antimicrobial residues in animal originated foods may induce serious health problems such as allergic reaction, antimicrobial resistance (AMR), and lead to carcinogenic and mutagenic effects in the human body. The misuse or abuse of antibiotics in human medicine is thought to be a principal cause of AMR but some antimicrobial-resistant bacteria and their resistant genes originating from animals are also responsible for developing AMR. However, the residual effect of antimicrobials in feed and food products of animal origin is undeniable. In developing countries, the community is unaware of this residual effect due to lack of proper information about antibiotic usage, AMR surveillance, and residue monitoring system. It is imperative to reveal the current situation of antimicrobial use in livestock production and its impacts on public health. Moreover, the safety levels of animal feeds and food products of animal origin must be strictly monitored and public awareness should be developed against the indiscriminate use of antimicrobial in animal production. Therefore, the current review summarizes the literature on antimicrobial use in livestock production and its hazardous residual impacts on the human body in developing countries.
- 5 January 2021
- Published by Veterinary World in Veterinary World
- Vol. 14 (1) , 210-221
Top Cited PapersOpen AccessAntimicrobial uses for livestock production in developing countries
Antimicrobial is an indispensable part of veterinary medicine used for the treatment and control of diseases as well as a growth promoter in livestock production. Frequent use of antimicrobials in veterinary practices may lead to the residue in animal originated products and creates some potential problems for human health. The presence of antimicrobial residues in animal originated foods may induce serious health problems such as allergic reaction, antimicrobial resistance (AMR), and lead to carcinogenic and mutagenic effects in the human body. The misuse or abuse of antibiotics in human medicine is thought to be a principal cause of AMR but some antimicrobial-resistant bacteria and their resistant genes originating from animals are also responsible for developing AMR. However, the residual effect of antimicrobials in feed and food products of animal origin is undeniable. In developing countries, the community is unaware of this residual effect due to lack of proper information about antibiotic usage, AMR surveillance, and residue monitoring system. It is imperative to reveal the current situation of antimicrobial use in livestock production and its impacts on public health. Moreover, the safety levels of animal feeds and food products of animal origin must be strictly monitored and public awareness should be developed against the indiscriminate use of antimicrobial in animal production. Therefore, the current review summarizes the literature on antimicrobial use in livestock production and its hazardous residual impacts on the human body in developing countries.
- 2 June 2017
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (7) , 1514-1520
Synergic modulation of the inflammatory state of macrophages utilizing anti-oxidant and phosphatidylserine-containing polymer–lipid hybrid nanoparticles
Bioactive particles directed the macrophage to anti-inflammatory phenotype.
- 2 June 2017
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (7) , 1514-1520
Synergic modulation of the inflammatory state of macrophages utilizing anti-oxidant and phosphatidylserine-containing polymer–lipid hybrid nanoparticles
Bioactive particles directed the macrophage to anti-inflammatory phenotype.
- 1 May 2017
- Published by Elsevier in Chemosphere
- Vol. 175, 200-209
Diuron causes sinking retardation and physiochemical alteration in marine diatoms Thalassiosira pseudonana and Skeletonema marinoi-dohrnii complex
- 1 May 2017
- Published by Elsevier in Chemosphere
- Vol. 175, 200-209
Diuron causes sinking retardation and physiochemical alteration in marine diatoms Thalassiosira pseudonana and Skeletonema marinoi-dohrnii complex
- 21 December 2016
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (2) , 415-421
Encapsulation of a nitric oxide donor into a liposome to boost the enhanced permeation and retention (EPR) effect
We propose a method to improve the enhanced permeability and retention (EPR) effect of nanomedicines based on tumor-specific vasodilation using a nitric oxide (NO) donor-containing PEGylated liposome.
- 21 December 2016
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (2) , 415-421
Encapsulation of a nitric oxide donor into a liposome to boost the enhanced permeation and retention (EPR) effect
We propose a method to improve the enhanced permeability and retention (EPR) effect of nanomedicines based on tumor-specific vasodilation using a nitric oxide (NO) donor-containing PEGylated liposome.
- 4 January 2016
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 27 (3) , 290-302
Synergy between phenotypic modulation and ROS neutralization in reduction of inflammatory response of hypoxic microglia by using phosphatidylserine and antioxidant containing liposomes
Neuroinflammation caused by microglial activation is a key contributing factor in neurological disorders such as those involving ischaemia. Excess production of reactive oxygen species (ROS) and nitric oxide (NO) stimulates the inflammatory response during ischaemia, significantly damaging cells. Inhibition of inflammatory activation of microglia is a promising potential treatment approach for neurological diseases. In this study, we introduce α-tocopherol and phosphatidylserine (PS) containing liposomes (PST-liposomes) to inhibit the microglial inflammatory response. PS is known to have anti-inflammatory effects on microglia by modulating the microglial phenotype, while α-tocopherol is an antioxidant, known to neutralize ROS. We found that both PS-containing liposomes (PS-liposomes) and PST-liposomes, as compared with phosphatidylcholine containing liposomes, significantly increased viability of hypoxia-treated microglia. The PST-liposomes functioned better than the PS-liposomes and we attribute this superior effect to a synergy between PS and α-tocopherol. This synergic action of PST-liposomes was illustrated in their ability, when incubated with microglia, to reduce NO and pro-inflammatory cytokine (TNF-α) production and increase anti-inflammatory cytokine (TGF-β1) production. Thus, the improved viability of hypoxia-treated microglia when treated with PST-liposomes involved anti-inflammatory effects, including ROS neutralization, as well as induction of a microglial phenotypic change. Our results suggest that PST-liposomes represent a potential therapeutic approach to reducing ischaemic injury in the brain.
- 4 January 2016
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 27 (3) , 290-302
Synergy between phenotypic modulation and ROS neutralization in reduction of inflammatory response of hypoxic microglia by using phosphatidylserine and antioxidant containing liposomes
Neuroinflammation caused by microglial activation is a key contributing factor in neurological disorders such as those involving ischaemia. Excess production of reactive oxygen species (ROS) and nitric oxide (NO) stimulates the inflammatory response during ischaemia, significantly damaging cells. Inhibition of inflammatory activation of microglia is a promising potential treatment approach for neurological diseases. In this study, we introduce α-tocopherol and phosphatidylserine (PS) containing liposomes (PST-liposomes) to inhibit the microglial inflammatory response. PS is known to have anti-inflammatory effects on microglia by modulating the microglial phenotype, while α-tocopherol is an antioxidant, known to neutralize ROS. We found that both PS-containing liposomes (PS-liposomes) and PST-liposomes, as compared with phosphatidylcholine containing liposomes, significantly increased viability of hypoxia-treated microglia. The PST-liposomes functioned better than the PS-liposomes and we attribute this superior effect to a synergy between PS and α-tocopherol. This synergic action of PST-liposomes was illustrated in their ability, when incubated with microglia, to reduce NO and pro-inflammatory cytokine (TNF-α) production and increase anti-inflammatory cytokine (TGF-β1) production. Thus, the improved viability of hypoxia-treated microglia when treated with PST-liposomes involved anti-inflammatory effects, including ROS neutralization, as well as induction of a microglial phenotypic change. Our results suggest that PST-liposomes represent a potential therapeutic approach to reducing ischaemic injury in the brain.
- 22 October 2015
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 26 (18) , 1465-1474
Suppression of atopic dermatitis in mice model by reducing inflammation utilizing phosphatidylserine-coated biodegradable microparticles
Controlling inflammatory response is important to avoid chronic inflammation in many diseases including atopic dermatitis (AD). In this research, we tried using a phosphatidylserine (PS)-coated microparticles in the AD mouse model for achieving the modulation of the macrophage phenotype to an anti-inflammatory state. Here, we prepared poly (D,L-lactic acid) microparticle coated with PS on the outside shell. We confirmed the cellular uptake of the PS-coated microparticle, which leads to the significant downregulation of the inflammatory cytokine production. In the mouse model of AD, the PS-coated microparticle was injected subcutaneously for a period of 12 days. The mice showed significant reduction in the development of AD symptoms comparing with the mice treated with the PC-coated microparticle.
- 22 October 2015
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 26 (18) , 1465-1474
Suppression of atopic dermatitis in mice model by reducing inflammation utilizing phosphatidylserine-coated biodegradable microparticles
Controlling inflammatory response is important to avoid chronic inflammation in many diseases including atopic dermatitis (AD). In this research, we tried using a phosphatidylserine (PS)-coated microparticles in the AD mouse model for achieving the modulation of the macrophage phenotype to an anti-inflammatory state. Here, we prepared poly (D,L-lactic acid) microparticle coated with PS on the outside shell. We confirmed the cellular uptake of the PS-coated microparticle, which leads to the significant downregulation of the inflammatory cytokine production. In the mouse model of AD, the PS-coated microparticle was injected subcutaneously for a period of 12 days. The mice showed significant reduction in the development of AD symptoms comparing with the mice treated with the PC-coated microparticle.